Skip to main content

Table 2 Comparison of average dose parameters for targets and OARs for left-sided breast cancers by treatment cohort

From: Cardiac dose reduction with deep inspiration breath hold for left-sided breast cancer radiotherapy patients with and without regional nodal irradiation

Parameter

WBRT

WBRT FB vs. DIBH p-value*

B/CWRT + RNI

B/CWRT FB vs. DIBH p-value***

All Patients

FB vs. DIBH

p-value*

CTVb Volume (cc)

      

 FB

515.5 ± 356.9

0.577

489.2 ± 200.8

0.496

503.7 ± 290.2

0.349

 DIBH

511.8 ± 354.6

491.3 ± 218.6

502.6 ± 294.0

D95 for CTVb (%)

      

 FB

97.3 ± 1.4

0.286

92.2 ± 8.1

0.030

95.0 ± 5.9

0.013

 DIBH

97.7 ± 1.3

96.2 ± 3.0

97.0 ± 2.3

V80 IMC (%)

      

FB

N/A

N/A

99.7 ± 0.9

1.000

N/A

N/A

DIBH

N/A

 

98.9 ± 3.3

N/A

Dmean Heart (cGy)

      

 FB

166.1 ± 71.0

0.001**

375.7 ± 186.0

0.004**

260.5 ± 169.3

<0.001**

 DIBH

110.8 ± 32.1

145.0 ± 37.7

126.2 ± 38.0

V25 Heart (%)

      

FB

0.8 ± 1.4

0.059

4.0 ± 3.4

0.014

2.2 ± 2.9

0.002**

DIBH

0.1 ± 0.4

0.0 ± 0.1

0.1 ± 0.3

Dmean LAD (cGy)

      

 FB

1004.6 ± 892.4

0.002**

1802.8 ± 917.8

0.004**

1363.8 ± 969.4

<0.001**

 DIBH

420.0 ± 277.4

396.2 ± 81.5

409.3 ± 208.4

V20 Left Lung (%)

      

 FB

10.5 ± 4.6

0.067

18.3 ± 5.1

0.250

14.0 ± 6.2

0.029

 DIBH

8.5 ± 3.6

16.3 ± 2.8

12.0 ± 5.1

Patients meeting

      

Dmean < 4Gy (fraction, %)

      

 FB

11/11 (100)

N/A

5/9 (56)

0.134

16/20 (80)

0.134

 DIBH

11/11 (100)

9/9 (100)

20/20 (100)

  1. Wilcoxon signed-rank test is used for comparison of all continuous variables, and McNemar's test is applied for discrete variables
  2. Significant p-values after adjusting for multiple testing are indicated by a double asterisk (**)
  3. Abbreviations: WBRT = whole breast RT ± boost cohort, B/CWRT + RNI = breast or chest wall + regional nodal RT cohort, FB = free-breathing, DIBH = deep inspiration breath hold, CTVb = CTV for breast or chest wall, IMC = internal mammary chain nodes, D95 = Dose to 95 % target volume,V80 = % volume of organ receiving 80 % of the prescription dose, V25 = % volume of organ receiving 25 Gy, Dmean = Mean dose, LAD = left anterior descending coronary artery, V20 = % volume of organ receiving 20 Gy, N/A = not applicable. Data shown are mean values with one standard deviation. *In this group, to achieve significance p-values must be < 0.0083 to account for multiple testing. ***In this group, to achieve significance p-values must be < 0.0071 to account for multiple testing. **Indicates significance when compared to the Bonferroni adjusted criterion